Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19

Ítems similars

• Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
  per: Peyvandi, Flora, et al.
  Publicat: (2010)
• Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
  per: Riva, Silvia, et al.
  Publicat: (2020)
• Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
  per: Ferrari, Barbara, et al.
  Publicat: (2014)
• Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis
  per: Peyvandi, Flora, et al.
  Publicat: (2021)
• Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura
  per: Rossio, Raffaella, et al.
  Publicat: (2013)